Breadcrumb
- Home
- Publications
- Proceedings
- 2010 Annual Meeting
- Food, Pharmaceutical & Bioengineering Division
- Systems Biotechnology
- (180d) Role of Redox Balancing and Reactive Oxygen Species in the Metabolic Phenotype of Tumor Cells
We are applying systems approaches to elucidate the role of cell-wide metabolic reprogramming to maintain redox homeostasis while optimizing intracellular ROS levels in tumor cells. We will present results from 13C metabolic flux analysis (MFA) applied to both normal FL5.12 B-cells and P493-6 lymphoma cells. These cell lines have been genetically modified to overexpress key oncoproteins including Akt or Myc as well as important metabolic enzymes such as Glut1 or hexokinase. This approach allows us to quantify how specific oncogenic signals redirect metabolic fluxes through NADPH- and ROS-producing pathways. We have observed that increased expression of the Myc oncoprotein results in a dose-dependent increase in ROS accumulation in P493-6 cells, which is associated with increased growth and upregulation of both glucose and glutamine metabolism. We will present results from 13C MFA studies aimed at elucidating the global metabolic alterations underlying these phenotypes, as well as how they respond to targeted interventions.